PGEN Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own PGEN shares is 180, representing 63.83% of the company's common stock.

CITADEL ADVISORS LLC, in the last quarter, reduced its stake in PGEN by -40.31% restricting it's holding to 317.26 thousand shares of worth nearly $460.02K. FORE CAPITAL, LLC also lessened -14.01% of the PGEN shares from its portfolio, reducing its holding to 306.79 thousand shares of worth $444.85K. ADVISOR GROUP HOLDINGS, INC. also shunned PGEN shares holding by -4.31% last quarter which brought its holding to 298.64 thousand shares worth $433.03K.

As per its latest 13F filing, METLIFE INVESTMENT MANAGEMENT, LLC increased its stake in PGEN by 2.27% in the last quarter. The institutional holder raised its holding to 67.67 thousand shares having worth more than $98.12K. INVESCO LTD. also added 0.29% more shares of PGEN to its portfolio, raising its holding to 44.61 thousand shares of worth $64.69K. PROSHARE ADVISORS LLC also increased its PGEN shares holding by 7.39% which brought its holding to 41.1 thousand shares worth $59.59K.

The insider with the most stakes in PGEN is Ares Trading S.A. , 10 percent owner at the company. Additionally, PGEN stock is highly held by President and CEO Sabzevari Helen and director Frank Steven among others.

Company executives, directors, and other insiders own 10.17% percent of Precigen, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which PGEN insiders have sold stock, totaling 0 shares. Insiders that have sold shares include KINDLER JEFFREY B, SABZEVARI HELEN, and THOMASIAN HARRY JR..

There have been 3 transaction(s) during the past 6-months in which Precigen, Inc. insiders have bought stock, totalling 23613234 shares

Around 65.32M Precigen, Inc. shares are held by insiders, which represents about 10.17% of PGEN stock.

PGEN 10 percent owner, Ares Trading S.A. holds the largest portfolio of the company's shares. PGEN shares owned by Ares total nearly 20.65 million.

METLIFE INVESTMENT MANAGEMENT, LLC is the largest institutional owner in PGEN which holds 67.67 thousand shares worth $98.12K or 0.03% of the total PGEN shares outstanding followed by INVESCO LTD. with ownership of 44.61 thousand shares representing 0.02% of the PGEN ownership. CWM, LLC is the third largest stakeholder with 42.91 thousand shares or 0.02% of the ownership worth more than $62.00K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the PGEN is concerned, it is a stock which is optionable.

Number of PGEN shares short is 15.32M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 292.87M shares of PGEN are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, PGEN has 117.76M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for PGEN is 24.02.